Advertisement

Index by author

May 01, 2004; Volume 309,Issue 2

  1. Ferrari, Bernard

    1. SSR240612 [(2R)-2-[((3R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization
      Jean Gougat, Bernard Ferrari, Lionel Sarran, Claudine Planchenault, Martine Poncelet, Jeanne Maruani, Richard Alonso, Annie Cudennec, Tiziano Croci, Fabio Guagnini, Katalin Urban-Szabo, Jean-Pierre Martinolle, Philippe Soubrié, Olivier Finance and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 661-669; DOI: https://doi.org/10.1124/jpet.103.059527

  2. Ferrendelli, James A.

    1. Enantioselectivity of α-Benzyl-α-methyl-γ-butyrolactone-Mediated Modulation of Anticonvulsant Activity and GABAA Receptor Function
      Eric B. Gonzales, Cathy L. Bell-Horner, Maria Antonette M. de la Cruz, James A. Ferrendelli, Douglas F. Covey and Glenn H. Dillon
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 677-683; DOI: https://doi.org/10.1124/jpet.103.063008

  3. Fezza, F.

    1. Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
      I. Matias, J. Chen, L. De Petrocellis, T. Bisogno, A. Ligresti, F. Fezza, A.H.-P. Krauss, L. Shi, C. E. Protzman, C. Li, Y. Liang, A. L. Nieves, K. M. Kedzie, R. M. Burk, V. Di Marzo and D. F. Woodward
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 745-757; DOI: https://doi.org/10.1124/jpet.103.061705

  4. Finance, Olivier

    1. SSR240612 [(2R)-2-[((3R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization
      Jean Gougat, Bernard Ferrari, Lionel Sarran, Claudine Planchenault, Martine Poncelet, Jeanne Maruani, Richard Alonso, Annie Cudennec, Tiziano Croci, Fabio Guagnini, Katalin Urban-Szabo, Jean-Pierre Martinolle, Philippe Soubrié, Olivier Finance and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 661-669; DOI: https://doi.org/10.1124/jpet.103.059527

  5. Fink, Gregory D.

    1. The Fenfluramine Metabolite (+)-Norfenfluramine Is Vasoactive
      Wei Ni, Melissa W. Li, Keshari Thakali, Gregory D. Fink and Stephanie W. Watts
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 845-852; DOI: https://doi.org/10.1124/jpet.103.060806

  6. Finnegan, Thomas F.

    1. Activation of μ-Opioid Receptors Inhibits Synaptic Inputs to Spinally Projecting Rostral Ventromedial Medulla Neurons
      Thomas F. Finnegan, De-Pei Li, Shao-Rui Chen and Hui-Lin Pan
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 476-483; DOI: https://doi.org/10.1124/jpet.103.064808

  7. Fischbach, Peter S.

    1. Risk of Ventricular Proarrhythmia with Selective Opening of the Myocardial Sarcolemmal versus Mitochondrial ATP-Gated Potassium Channel
      Peter S. Fischbach, Andrew White, Terrance D. Barrett and Benedict R. Lucchesi
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 554-559; DOI: https://doi.org/10.1124/jpet.103.060780

  8. Fisher, Craig D.

    1. Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor
      Niel C. Hoglen, Long-Shiuh Chen, Craig D. Fisher, Brad P. Hirakawa, Todd Groessl and Patricia C. Contreras
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 634-640; DOI: https://doi.org/10.1124/jpet.103.062034

  9. Fleckenstein, Annette E.

    1. Alterations in Vesicular Dopamine Uptake Contribute to Tolerance to the Neurotoxic Effects of Methamphetamine
      Kamisha L. Johnson-Davis, Jannine G. Truong, Annette E. Fleckenstein and Diana G. Wilkins
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 578-586; DOI: https://doi.org/10.1124/jpet.103.062695

  10. Forrest, M.

    1. Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes
      M. Forrest, S.-Y. Sun, R. Hajdu, J. Bergstrom, D. Card, G. Doherty, J. Hale, C. Keohane, C. Meyers, J. Milligan, S. Mills, N. Nomura, H. Rosen, M. Rosenbach, G.-J. Shei, I. I. Singer, M. Tian, S. West, V. White, J. Xie, R. L. Proia and S. Mandala
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 758-768; DOI: https://doi.org/10.1124/jpet.103.062828
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement